Company
Samsara Biocapital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Claris Biotherapeutics, Inc. | Series B | 2026-08-03 | Lead |
| Nura Bio Inc | Series B | 2026-06-22 | |
| Memento Medicines | Series A | 2026-06-19 | |
| Ambrosia Biosciences | Series B | 2026-03-31 | |
| Primmune Therapeutics | Series B | 2026-01-30 | |
| PsiThera | Series A | 2025-12-16 | Lead |
| SpyGlass Pharma | Series D | 2025-06-02 | |
| Alpheus Medical | Series B | 2025-05-15 | Lead |
| Abcuro | Series C | 2025-02-13 | |
| Normunity | Series B | 2025-01-13 | Lead |
| A2 Biotherapeutics | Series C | 2025-01-09 | |
| Candid Therapeutics | Funding | 2024-09-09 | |
| Enlaza Therapeutics | Series A Funding | 2024-04-30 | |
| Alumis | Series C Financing | 2024-03-07 | Lead |
| FogPharma | Series E Funding | 2024-03-03 | |
| Seismic Therapeutic | Series B | 2023-12-04 | |
| Abcuro | Series B Financing | 2023-08-18 | |
| Septerna | Series B Financing | 2023-07-17 | |
| Palvella Therapeutics | Series D | 2023-01-09 | |
| Enlaza Therapeutics | Seed | 2022-12-19 | |
| DELFI Diagnostics | Series B | 2022-07-18 |